WDR4 and cancer: In KIRC, the expressions of METT1 and WDR4 in cancer samples were significantly greater vs. healthy samples (p < 0.01), the greater the expressing levels of METT1 and WDR4, the worse the prognoses of KIRC sufferers (Figures 2C,D).